Melatonin mini-tablets and method of manufacturing the same
AU2016426598A1
Melatonin mini-tablets and method of manufacturing the same
US2014377351A1
Method and composition for enhancing cognition in alzheimer's patients
IL228354D0
Neuroprotective peptides
US2013324583A1
Methods for treating neurological disease
HK1164136A1
Method and formulation for treating resistance to antihypertensives and related conditions
KR20140036164A
Neuroprotective peptides
NZ582390A
Cd44 splice variants in neurodegenerative diseases
US2008132559A1
Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
US2008027121A1
Pyrone-indole derivatives and process for their preparation
IL157260D0
New use for melatonin and melatonin agonists
IL156669D0
2-aminobenzoyl derivatives
IL155666D0
Composition for treating insomnia
ZA200206228B
Method and formulation for treating resistance to antihypertensives and related conditions.
IL150190A
Use of melatonin in the manufacture of controlled release medicaments for inprovement in mood and daytime vigilance, modifying the 24-hour cortisol profile, protection against carodic ischemia, and prevention or treatment of hypertension in a patient resistant to other antihypertensive drugs
IL149377D0
Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL144900D0
Melatonin and medicaments comprising it for use in treating primary insomnia and in the manufacture of such medicaments
IL138825D0
Pharmaceutical formulations containing derivatives of tryptamine and analogous compounds, and some such novel compounds
IL150190D0
Method and formulation for treating resistance to antihypertensives and related conditions
IL130171D0
Melatonin for use in the prevention and treatment of tardive dyskinesia, pharmaceutical formulations comprising it and its use for the manufacture of medicaments
